Abiomed

Abiomed is a leading provider of medical devices that provide circulatory support. Our products are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. CEO, Chairman, and President Michael R. Minogue has focused the company’s efforts on developing ground-breaking technologies designed to improve the patient outcomes focused on native heart recovery. Founded in 1981 for the purpose of developing the world’s first artificial heart, Abiomed has remained dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.

Follow on social Media
Listen to Jeff Moses, MD, Director, Interventional Cardiovascular Therapeutics at Columbia University Medical Center, present Contemporary Practices of HR-PCI with Percutaneous MCS: Results from PROTECT III, The Largest Prospective Multi-Center Single-Arm Study.
PRODUCTS
Doc1
Impella CP with SmartAssist
Doc1
Impella Procedure with Single-Access Technique
Doc1
Remote Impella Support
GET IN TOUCH